RXRX · Recursion Pharmaceuticals, Inc. · Debt
$3.70
+0.12 (+3.35%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$1.98B
Shares
535.34M
Volume · Oct 23
19.08M
Avg daily vol (3M)
21.75M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current long-term debt and lease obligations | 2026-06-30 | USD 9,443,000 | 10-Q filed 2026-08-05 |
| Current operating lease liabilities | 2026-06-30 | USD 13,249,000 | 10-Q filed 2026-08-05 |
| Finance lease liabilities | 2026-06-30 | USD 13,900,000 | 10-Q filed 2026-08-05 |
| Noncurrent long-term debt and lease obligations | 2026-06-30 | USD 4,753,000 | 10-Q filed 2026-08-05 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 39,193,000 | 10-Q filed 2026-08-05 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1601830
CUSIP
75629V104
13F (30d)
51 filings
51 filers
Visit website
Investor relations